Holly L. Thacker, MD, FACP, NCMP, CCD

Andrea Sikon, MD
The Women’s Health Center at the Gault Women’s Health and Breast Pavilion, Department of General Internal Medicine, The Cleveland Clinic Foundation; Certified North American Menopause Society Menopause Clinician

Holly L. Thacker, MD
Director, The Women’s Health Center at the Gault Women’s Health and Breast Pavilion, Department of General Internal Medicine, and Department of Obstetrics and Gynecology, The Cleveland Clinic Foundation; Certified North American Menopause Society Menopause Clinician

Address: Holly L. Thacker, MD, FACP, Women’s Health Center at the Gault Women’s Health and Breast Pavilion, A10, The Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, OH 44195; e-mail thackeh@ccf.org

This paper discusses therapies that are experimental or are not approved by the US Food and Drug Administration for the use under discussion.

Andrea Sikon, MD
The Women’s Health Center at the Gault Women’s Health and Breast Pavilion, Department of General Internal Medicine, The Cleveland Clinic Foundation; Certified North American Menopause Society Menopause Clinician

Holly L. Thacker, MD
Director, The Women’s Health Center at the Gault Women’s Health and Breast Pavilion, Department of General Internal Medicine, and Department of Obstetrics and Gynecology, The Cleveland Clinic Foundation; Certified North American Menopause Society Menopause Clinician

Address: Holly L. Thacker, MD, FACP, Women’s Health Center at the Gault Women’s Health and Breast Pavilion, A10, The Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, OH 44195; e-mail thackeh@ccf.org

This paper discusses therapies that are experimental or are not approved by the US Food and Drug Administration for the use under discussion.

Andrea Sikon, MD
The Women’s Health Center at the Gault Women’s Health and Breast Pavilion, Department of General Internal Medicine, The Cleveland Clinic Foundation; Certified North American Menopause Society Menopause Clinician

Holly L. Thacker, MD
Director, The Women’s Health Center at the Gault Women’s Health and Breast Pavilion, Department of General Internal Medicine, and Department of Obstetrics and Gynecology, The Cleveland Clinic Foundation; Certified North American Menopause Society Menopause Clinician

Address: Holly L. Thacker, MD, FACP, Women’s Health Center at the Gault Women’s Health and Breast Pavilion, A10, The Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, OH 44195; e-mail thackeh@ccf.org

This paper discusses therapies that are experimental or are not approved by the US Food and Drug Administration for the use under discussion.

Gurjit Kaur, DO
Department of General Internal Medicine, Women’s Health Center at The Gault Women’s Health and Breast Pavilion, The Cleveland Clinic Foundation

Lilian Gonsalves, MD
Department of Psychiatry and Psychology, Women’s Health Center at The Gault Women’s Health and Breast Pavilion, The Cleveland Clinic Foundation

Holly L. Thacker, MD
Department of General Internal Medicine, Department of Obstetrics and Gynecology, Women’s Health Center at The Gault Women’s Health and Breast Pavilion, The Cleveland Clinic Foundation

Address: Gurjit Kaur, DO, Department of General Internal Medicine, A91, The Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, OH 44195; e-mail kaurg@ccf.org

This paper discusses therapies that are experimental or are not approved by the US Food and Drug Adminstration for the use under discussion.

Gurjit Kaur, DO
Department of General Internal Medicine, Women’s Health Center at The Gault Women’s Health and Breast Pavilion, The Cleveland Clinic Foundation

Lilian Gonsalves, MD
Department of Psychiatry and Psychology, Women’s Health Center at The Gault Women’s Health and Breast Pavilion, The Cleveland Clinic Foundation

Holly L. Thacker, MD
Department of General Internal Medicine, Department of Obstetrics and Gynecology, Women’s Health Center at The Gault Women’s Health and Breast Pavilion, The Cleveland Clinic Foundation

Address: Gurjit Kaur, DO, Department of General Internal Medicine, A91, The Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, OH 44195; e-mail kaurg@ccf.org

This paper discusses therapies that are experimental or are not approved by the US Food and Drug Adminstration for the use under discussion.

Gurjit Kaur, DO
Department of General Internal Medicine, Women’s Health Center at The Gault Women’s Health and Breast Pavilion, The Cleveland Clinic Foundation

Lilian Gonsalves, MD
Department of Psychiatry and Psychology, Women’s Health Center at The Gault Women’s Health and Breast Pavilion, The Cleveland Clinic Foundation

Holly L. Thacker, MD
Department of General Internal Medicine, Department of Obstetrics and Gynecology, Women’s Health Center at The Gault Women’s Health and Breast Pavilion, The Cleveland Clinic Foundation

Address: Gurjit Kaur, DO, Department of General Internal Medicine, A91, The Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, OH 44195; e-mail kaurg@ccf.org

This paper discusses therapies that are experimental or are not approved by the US Food and Drug Adminstration for the use under discussion.

Holly L. Thacker, MD
Head, Section of Women’s Health, Women’s Health Center; Director, Women’s Health Track, General Internal Medicine Fellowship, The Cleveland Clinic

Address: Holly L. Thacker, MD, Women’s Health Center, A10, The Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, OH 44195; e-mail thackeh@ccf.org

Dr. Thacker has indicated that she serves on the speakers’ bureaus of the Pfizer, Wyeth-Ayerst, Eli Lilly, and Merck corporations.

This paper discusses therapies that are not approved by the US Food and Drug Administration for the use under discussion.

Medical Grand Rounds articles are based on edited transcripts from Division of Medicine Grand Rounds presentations at The Cleveland Clinic. They are approved by the author but are not peer-reviewed.

Holly L. Thacker, MD
Head, Section of Women’s Health, Women’s Health Center; Director, Women’s Health Track, General Internal Medicine Fellowship, The Cleveland Clinic

Address: Holly L. Thacker, MD, Women’s Health Center, A10, The Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, OH 44195; e-mail thackeh@ccf.org

Dr. Thacker has indicated that she serves on the speakers’ bureaus of the Pfizer, Wyeth-Ayerst, Eli Lilly, and Merck corporations.

This paper discusses therapies that are not approved by the US Food and Drug Administration for the use under discussion.

Medical Grand Rounds articles are based on edited transcripts from Division of Medicine Grand Rounds presentations at The Cleveland Clinic. They are approved by the author but are not peer-reviewed.

Holly L. Thacker, MD
Head, Section of Women’s Health, Women’s Health Center; Director, Women’s Health Track, General Internal Medicine Fellowship, The Cleveland Clinic

Address: Holly L. Thacker, MD, Women’s Health Center, A10, The Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, OH 44195; e-mail thackeh@ccf.org

Dr. Thacker has indicated that she serves on the speakers’ bureaus of the Pfizer, Wyeth-Ayerst, Eli Lilly, and Merck corporations.

This paper discusses therapies that are not approved by the US Food and Drug Administration for the use under discussion.

Medical Grand Rounds articles are based on edited transcripts from Division of Medicine Grand Rounds presentations at The Cleveland Clinic. They are approved by the author but are not peer-reviewed.

Hani Jneid, MD
Department of Internal Medicine, Cleveland Clinic

Holly L. Thacker, MD, FACP
Head, Section of Women’s Health, Departments of General Internal Medicine and Obstetrics and Gynecology, Cleveland Clinic; Director of Women’s Health Track GIM Fellowship, Clinical Associate Professor of Medicine, Penn State University

Address: Holly L. Thacker, MD, FACP, Department of General Internal Medicine and Obstetrics and Gynecology, A91, Cleveland Clinic, 9500 Euclid Avenue, Cleveland, OH 44195;
thackeh@ccf.org

This paper discusses treatment information that is “off-label,” ie, not approved by the Food and Drug Administration for the indication under discussion.

Hani Jneid, MD
Department of Internal Medicine, Cleveland Clinic

Holly L. Thacker, MD, FACP
Head, Section of Women’s Health, Departments of General Internal Medicine and Obstetrics and Gynecology, Cleveland Clinic; Director of Women’s Health Track GIM Fellowship, Clinical Associate Professor of Medicine, Penn State University

Address: Holly L. Thacker, MD, FACP, Department of General Internal Medicine and Obstetrics and Gynecology, A91, Cleveland Clinic, 9500 Euclid Avenue, Cleveland, OH 44195;
thackeh@ccf.org

This paper discusses treatment information that is “off-label,” ie, not approved by the Food and Drug Administration for the indication under discussion.

Hani Jneid, MD
Department of Internal Medicine, Cleveland Clinic

Holly L. Thacker, MD, FACP
Head, Section of Women’s Health, Departments of General Internal Medicine and Obstetrics and Gynecology, Cleveland Clinic; Director of Women’s Health Track GIM Fellowship, Clinical Associate Professor of Medicine, Penn State University

Address: Holly L. Thacker, MD, FACP, Department of General Internal Medicine and Obstetrics and Gynecology, A91, Cleveland Clinic, 9500 Euclid Avenue, Cleveland, OH 44195;
thackeh@ccf.org

This paper discusses treatment information that is “off-label,” ie, not approved by the Food and Drug Administration for the indication under discussion.

Holly L. Thacker, MD, FACP
Head, Section of Women’s Health, Department of Internal Medicine and Department of Gynecology and Obstetrics, Cleveland Clinic

Address: Holly L. Thacker, MD, FACP, Department of Internal Medicine, A91, Cleveland Clinic, 9500 Euclid Avenue, Cleveland, OH 44195, thackeh@ccf.org

Holly L. Thacker, MD, FACP
Head, Section of Women’s Health, Department of Internal Medicine and Department of Gynecology and Obstetrics, Cleveland Clinic

Address: Holly L. Thacker, MD, FACP, Department of Internal Medicine, A91, Cleveland Clinic, 9500 Euclid Avenue, Cleveland, OH 44195, thackeh@ccf.org

Holly L. Thacker, MD, FACP
Head, Section of Women’s Health, Department of Internal Medicine and Department of Gynecology and Obstetrics, Cleveland Clinic

Address: Holly L. Thacker, MD, FACP, Department of Internal Medicine, A91, Cleveland Clinic, 9500 Euclid Avenue, Cleveland, OH 44195, thackeh@ccf.org